Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Targinta
Tag: Targinta
Targinta’s CEO: “Strong interest in ADCs in 2023”
22 January, 2024
Targinta positions itself in the ADC field
22 March, 2023
Xintela’s strategy for 2023
17 February, 2023
Targinta takes lead in the ADC field in the Nordics
23 May, 2022
Targinta’s CEO comments on preclinical data in TNBC and the spin-out
13 April, 2022
Xintela presents the plans for 2022 in its Q4 report
4 March, 2022
BioStock Investor Meeting, March 16
27 January, 2022
Xintela advances to clinical phase in OA and difficult-to-heal wounds in...
19 January, 2022
Targinta’s CEO on TARG10 and the spin-off
22 October, 2021
Join us for the BioStock Life Science Summit on October 20...
20 October, 2021
1
2
Page 1 of 2
